As of Jan 13
| -0.10 / -0.05%|
The 20 analysts offering 12-month price forecasts for Allergan have a median target of 256.50, with a high estimate of 400.00 and a low estimate of 202.00. The median estimate represents a +18.67% increase from the last price of 216.14.
The current consensus among 25 polled investment analysts is to Buy stock in Allergan. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.